Cargando…

p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions

BACKGROUND: As an important cellular stress sensor phosphoprotein p53 can trigger cell cycle arrest and apoptosis and regulate autophagy. The p53 activity mainly depends on its transactivating function, however, how p53 can select one or another biological outcome is still a matter of profound studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Garufi, Alessia, Pistritto, Giuseppa, Baldari, Silvia, Toietta, Gabriele, Cirone, Mara, D’Orazi, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594515/
https://www.ncbi.nlm.nih.gov/pubmed/28893313
http://dx.doi.org/10.1186/s13046-017-0596-z
_version_ 1783263218837225472
author Garufi, Alessia
Pistritto, Giuseppa
Baldari, Silvia
Toietta, Gabriele
Cirone, Mara
D’Orazi, Gabriella
author_facet Garufi, Alessia
Pistritto, Giuseppa
Baldari, Silvia
Toietta, Gabriele
Cirone, Mara
D’Orazi, Gabriella
author_sort Garufi, Alessia
collection PubMed
description BACKGROUND: As an important cellular stress sensor phosphoprotein p53 can trigger cell cycle arrest and apoptosis and regulate autophagy. The p53 activity mainly depends on its transactivating function, however, how p53 can select one or another biological outcome is still a matter of profound studies. Our previous findings indicate that switching cancer cells in high glucose (HG) impairs p53 apoptotic function and the transcription of target gene PUMA. METHODS AND RESULTS: Here we report that, in response to drug adriamycin (ADR) in HG, p53 efficiently induced the expression of DRAM (damage-regulated autophagy modulator), a p53 target gene and a stress-induced regulator of autophagy. We found that ADR treatment of cancer cells in HG increased autophagy, as displayed by greater LC3II accumulation and p62 degradation compared to ADR-treated cells in low glucose. The increased autophagy in HG was in part dependent on p53-induced DRAM; indeed DRAM knockdown with specific siRNA reversed the expression of the autophagic markers in HG. A similar outcome was achieved by inhibiting p53 transcriptional activity with pifithrin-α. DRAM knockdown restored the ADR-induced cell death in HG to the levels obtained in low glucose. A similar outcome was achieved by inhibition of autophagy with cloroquine (CQ) or with silencing of autophagy gene ATG5. DRAM knockdown or inhibition of autophagy were both able to re-induce PUMA transcription in response to ADR, underlining a reciprocal interplay between PUMA to DRAM to unbalance p53 apoptotic activity in HG. Xenograft tumors transplanted in normoglycemic mice displayed growth delay after ADR treatment compared to those transplanted in diabetics mice and such different in vivo response correlated with PUMA to DRAM gene expression. CONCLUSIONS: Altogether, these findings suggest that in normal/high glucose condition a mutual unbalance between p53-dependent apoptosis (PUMA) and autophagy (DRAM) gene occurred, modifying the ADR-induced cancer cell death in HG both in vitro and in vivo.
format Online
Article
Text
id pubmed-5594515
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55945152017-09-14 p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions Garufi, Alessia Pistritto, Giuseppa Baldari, Silvia Toietta, Gabriele Cirone, Mara D’Orazi, Gabriella J Exp Clin Cancer Res Research BACKGROUND: As an important cellular stress sensor phosphoprotein p53 can trigger cell cycle arrest and apoptosis and regulate autophagy. The p53 activity mainly depends on its transactivating function, however, how p53 can select one or another biological outcome is still a matter of profound studies. Our previous findings indicate that switching cancer cells in high glucose (HG) impairs p53 apoptotic function and the transcription of target gene PUMA. METHODS AND RESULTS: Here we report that, in response to drug adriamycin (ADR) in HG, p53 efficiently induced the expression of DRAM (damage-regulated autophagy modulator), a p53 target gene and a stress-induced regulator of autophagy. We found that ADR treatment of cancer cells in HG increased autophagy, as displayed by greater LC3II accumulation and p62 degradation compared to ADR-treated cells in low glucose. The increased autophagy in HG was in part dependent on p53-induced DRAM; indeed DRAM knockdown with specific siRNA reversed the expression of the autophagic markers in HG. A similar outcome was achieved by inhibiting p53 transcriptional activity with pifithrin-α. DRAM knockdown restored the ADR-induced cell death in HG to the levels obtained in low glucose. A similar outcome was achieved by inhibition of autophagy with cloroquine (CQ) or with silencing of autophagy gene ATG5. DRAM knockdown or inhibition of autophagy were both able to re-induce PUMA transcription in response to ADR, underlining a reciprocal interplay between PUMA to DRAM to unbalance p53 apoptotic activity in HG. Xenograft tumors transplanted in normoglycemic mice displayed growth delay after ADR treatment compared to those transplanted in diabetics mice and such different in vivo response correlated with PUMA to DRAM gene expression. CONCLUSIONS: Altogether, these findings suggest that in normal/high glucose condition a mutual unbalance between p53-dependent apoptosis (PUMA) and autophagy (DRAM) gene occurred, modifying the ADR-induced cancer cell death in HG both in vitro and in vivo. BioMed Central 2017-09-11 /pmc/articles/PMC5594515/ /pubmed/28893313 http://dx.doi.org/10.1186/s13046-017-0596-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Garufi, Alessia
Pistritto, Giuseppa
Baldari, Silvia
Toietta, Gabriele
Cirone, Mara
D’Orazi, Gabriella
p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
title p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
title_full p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
title_fullStr p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
title_full_unstemmed p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
title_short p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
title_sort p53-dependent puma to dram antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594515/
https://www.ncbi.nlm.nih.gov/pubmed/28893313
http://dx.doi.org/10.1186/s13046-017-0596-z
work_keys_str_mv AT garufialessia p53dependentpumatodramantagonisticinterplayasakeymolecularswitchincellfatedecisioninnormalhighglucoseconditions
AT pistrittogiuseppa p53dependentpumatodramantagonisticinterplayasakeymolecularswitchincellfatedecisioninnormalhighglucoseconditions
AT baldarisilvia p53dependentpumatodramantagonisticinterplayasakeymolecularswitchincellfatedecisioninnormalhighglucoseconditions
AT toiettagabriele p53dependentpumatodramantagonisticinterplayasakeymolecularswitchincellfatedecisioninnormalhighglucoseconditions
AT cironemara p53dependentpumatodramantagonisticinterplayasakeymolecularswitchincellfatedecisioninnormalhighglucoseconditions
AT dorazigabriella p53dependentpumatodramantagonisticinterplayasakeymolecularswitchincellfatedecisioninnormalhighglucoseconditions